Construction and Characterization of an Attenuated Purine Auxotroph in aFrancisella tularensisLive Vaccine Strain
- 1 August 2006
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 74 (8) , 4452-4461
- https://doi.org/10.1128/iai.00666-06
Abstract
Francisella tularensisis a facultative intracellular pathogen and is the etiological agent of tularemia. It is capable of escaping from the phagosome, replicating to high numbers in the cytosol, and inducing apoptosis in macrophages of a variety of hosts.F. tularensishas received significant attention recently due to its potential use as a bioweapon. Currently, there is no licensed vaccine againstF. tularensis, although a partially protective live vaccine strain (LVS) that is attenuated in humans but remains fully virulent for mice was previously developed. AnF. tularensisLVS mutant deleted in thepurMCDpurine biosynthetic locus was constructed and partially characterized by using an allelic exchange strategy. TheF. tularensisLVS ΔpurMCDmutant was auxotrophic for purines when grown in defined medium and exhibited significant attenuation in virulence when assayed in murine macrophages in vitro or in BALB/c mice. Growth and virulence defects were complemented by the addition of the purine precursor hypoxanthine or by introduction ofpurMCDNintrans. TheF. tularensisLVS ΔpurMCDmutant escaped from the phagosome but failed to replicate in the cytosol or induce apoptotic and cytopathic responses in infected cells. Importantly, mice vaccinated with a low dose of theF. tularensisLVSΔpurMCDmutant were fully protected against subsequent lethal challenge with the LVS parental strain. Collectively, these results suggest thatF. tularensismutants deleted in thepurMCDbiosynthetic locus exhibit characteristics that may warrant further investigation of their use as potential live vaccine candidates.Keywords
This publication has 50 references indexed in Scilit:
- Adenosine Inhibits Tumor Necrosis Factor-α Release from Mouse Peritoneal Macrophages via A2A and A2B but Not the A3 Adenosine ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2006
- In Vivo Himar1 -Based Transposon Mutagenesis of Francisella tularensisApplied and Environmental Microbiology, 2006
- Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of diseaseVaccine, 2005
- The complete genome sequence of Francisella tularensis, the causative agent of tularemiaNature Genetics, 2005
- Construction and Characterization of a Highly Efficient Francisella Shuttle PlasmidApplied and Environmental Microbiology, 2004
- An Attenuated Strain of the Facultative Intracellular BacteriumFrancisella tularensisCan Escape the Phagosome of Monocytic CellsInfection and Immunity, 2003
- Francisella tularensisInduces Cytopathogenicity and Apoptosis in Murine Macrophages via a Mechanism That Requires Intracellular Bacterial MultiplicationInfection and Immunity, 2001
- Sequencing of theFrancisella tularensisStrain Schu 4 Genome Reveals the Shikimate and Purine Metabolic Pathways, Targets for the Construction of a Rationally Attenuated Auxotrophic VaccineMicrobial & Comparative Genomics, 2000
- The tularaemia vaccineJournal of Chemical Technology & Biotechnology, 1994
- Immunization against Tularemia: Analysis of the Effectiveness of Live Francisella tularensis Vaccine in Prevention of Laboratory-Acquired TularemiaThe Journal of Infectious Diseases, 1977